Callos Andrew
EVP, Chief Commercial Officer
Callos Andrew has filed 25 SEC Form 4 filings (50 transaction rows) across 1 company, with disclosures dating back to 2025. 25 of those filings fall inside the rolling window. Most recent filing: Aug 31, 2026.
On the most recent filing, Callos Andrew is listed as EVP, Chief Commercial Officer at CYTOKINETICS INC. Inside the rolling window, Callos Andrew reported no open-market purchases and 22 open-market sales totaling $16.0M in CYTK. The largest disclosed transaction in the window is a sale of 52,486 CYTK shares on Dec 5, 2025, worth $3.5M.
Companies traded
Other insiders at CYTK
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$16.0M
reported sales (SEC code S)
Companies
1
in the rolling window
| Source | |||||||
|---|---|---|---|---|---|---|---|
| CYTK | EVP, Chief Commercial Officer | Sale | 10,000 | $702K | Aug 31 | SEC ↗ | |
| CYTK | EVP, Chief Commercial Officer | Sale | 14,000 | $1.1M | Jul 30 | SEC ↗ | |
| CYTK | EVP, Chief Commercial Officer | Sale | 15,000 | $1.3M | Jul 2 | SEC ↗ | |
| CYTK | EVP, Chief Commercial Officer | Sale | 15,000 | $1.1M | Jun 1 | SEC ↗ | |
| CYTK | EVP, Chief Commercial Officer | Sale | 11,333 | $875K | May 5 | SEC ↗ | |
| CYTK | EVP, Chief Commercial Officer | Sale | 15,857 | $1.0M | May 4 | SEC ↗ | |
| CYTK | EVP, Chief Commercial Officer | Sale | 15,000 | $949K | Apr 30 | SEC ↗ | |
| CYTK | EVP, Chief Commercial Officer | Sale | 7,449 | $492K | Apr 15 | SEC ↗ | |
| CYTK | EVP, Chief Commercial Officer | Sale | 3,639 | $237K | Mar 31 | SEC ↗ | |
| CYTK | EVP, Chief Commercial Officer | Sale | 8,542 | $531K | Mar 18 | SEC ↗ | |
| CYTK | EVP, Chief Commercial Officer | Sale | 1,930 | $120K | Mar 18 | SEC ↗ | |
| CYTK | EVP, Chief Commercial Officer | Sale | 1,709 | $104K | Mar 16 | SEC ↗ | |
| CYTK | EVP, Chief Commercial Officer | Sale | 2,582 | $157K | Mar 10 | SEC ↗ | |
| CYTK | EVP, Chief Commercial Officer | Sale | 26,000 | $1.6M | Mar 5 | SEC ↗ | |
| CYTK | EVP, Chief Commercial Officer | Sale | 886 | $55K | Mar 2 | SEC ↗ | |
| CYTK | EVP, Chief Commercial Officer | Sale | 15,000 | $929K | Feb 5 | SEC ↗ | |
| CYTK | EVP, Chief Commercial Officer | Sale | 886 | $55K | Feb 2 | SEC ↗ | |
| CYTK | EVP, Chief Commercial Officer | Sale | 15,000 | $904K | Jan 5 | SEC ↗ | |
| CYTK | EVP, Chief Commercial Officer | Sale | 1,798 | $113K | Jan 2 | SEC ↗ | |
| CYTK | EVP, Chief Commercial Officer | Sale | 1,809 | $113K | Dec 30 | SEC ↗ | |
| CYTK | EVP, Chief Commercial Officer | Sale | 1,042 | $69K | Dec 8 | SEC ↗ | |
| CYTK | EVP, Chief Commercial Officer | Sale | 52,486 | $3.5M | Dec 5 | SEC ↗ |
Frequently asked questions
How many SEC Form 4 filings has Callos Andrew made?
Callos Andrew has filed 25 SEC Form 4 filings (50 transaction rows) across 1 company since 2025.
Which companies does Callos Andrew trade?
Callos Andrew has filed SEC Form 4 disclosures for 1 company, including CYTK.
When was Callos Andrew's most recent SEC Form 4 filing?
Callos Andrew's most recent SEC Form 4 filing on Tracefour is dated Aug 31, 2026.
What is Callos Andrew's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Callos Andrew is listed as EVP, Chief Commercial Officer.
What is Callos Andrew's total buy and sell value in the current window?
Inside the rolling retention window, Callos Andrew bought $0 and sold $16.0M based on SEC Form 4 filings.
What was Callos Andrew's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 52,486 CYTK shares on 2025-12-05, worth $3.5M, per SEC Form 4 filings.